It is noteworthy that regions of the brain that were not affected by AD pathology, such as the cerebellum, had NSun2 levels comparable to those in the control cerebellum, indicating that NSun2 deficiency is limited to those brain regions most vulnerable to AD (Kim et al., 2022). The gene discussed is NSUN2; the disease is Alzheimer disease.